Cargando…
Paracentral acute middle maculopathy in Susac syndrome after dual exposure to SARS-CoV-2 antigen
We report a case of Susac syndrome after SARS-CoV-2 infection and subsequent vaccination that presented with meningitis and retinal microembolisation in the form of paracentral acute middle maculopathy (PAMM). After presenting with headache, fever and myalgia followed by scotomata, a woman in her 50...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092144/ https://www.ncbi.nlm.nih.gov/pubmed/35537770 http://dx.doi.org/10.1136/bcr-2021-247159 |
_version_ | 1784705079868129280 |
---|---|
author | Malerbi, Fernando Korn Schoeps, Vinicius Andreoli T F Matos, Kimble |
author_facet | Malerbi, Fernando Korn Schoeps, Vinicius Andreoli T F Matos, Kimble |
author_sort | Malerbi, Fernando Korn |
collection | PubMed |
description | We report a case of Susac syndrome after SARS-CoV-2 infection and subsequent vaccination that presented with meningitis and retinal microembolisation in the form of paracentral acute middle maculopathy (PAMM). After presenting with headache, fever and myalgia followed by scotomata, a woman in her 50s was hospitalised for meningitis; she had had mild COVID-19 infection 2 months prior to admission, having received the first vaccine dose 1 month prior to the neurological manifestation. Eye fundus examination and optical coherence tomography were suggestive of PAMM. D-dimer levels and erythrocyte sedimentation rate were elevated. Before infectious investigation results were available, she was started on empirical antibiotic and antiviral treatment. Having ruled out infectious causes, she was started on high-dose prednisolone. After 1 month, there was partial resolution of retinal lesions. This case highlights that exposure to SARS-CoV-2 antigen may be related to this rare syndrome; treatment with steroids may improve central and retinal impairment. |
format | Online Article Text |
id | pubmed-9092144 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-90921442022-05-27 Paracentral acute middle maculopathy in Susac syndrome after dual exposure to SARS-CoV-2 antigen Malerbi, Fernando Korn Schoeps, Vinicius Andreoli T F Matos, Kimble BMJ Case Rep Case Reports: Unusual association of diseases/symptoms We report a case of Susac syndrome after SARS-CoV-2 infection and subsequent vaccination that presented with meningitis and retinal microembolisation in the form of paracentral acute middle maculopathy (PAMM). After presenting with headache, fever and myalgia followed by scotomata, a woman in her 50s was hospitalised for meningitis; she had had mild COVID-19 infection 2 months prior to admission, having received the first vaccine dose 1 month prior to the neurological manifestation. Eye fundus examination and optical coherence tomography were suggestive of PAMM. D-dimer levels and erythrocyte sedimentation rate were elevated. Before infectious investigation results were available, she was started on empirical antibiotic and antiviral treatment. Having ruled out infectious causes, she was started on high-dose prednisolone. After 1 month, there was partial resolution of retinal lesions. This case highlights that exposure to SARS-CoV-2 antigen may be related to this rare syndrome; treatment with steroids may improve central and retinal impairment. BMJ Publishing Group 2022-05-10 /pmc/articles/PMC9092144/ /pubmed/35537770 http://dx.doi.org/10.1136/bcr-2021-247159 Text en © BMJ Publishing Group Limited 2022. No commercial re-use. See rights and permissions. Published by BMJ. |
spellingShingle | Case Reports: Unusual association of diseases/symptoms Malerbi, Fernando Korn Schoeps, Vinicius Andreoli T F Matos, Kimble Paracentral acute middle maculopathy in Susac syndrome after dual exposure to SARS-CoV-2 antigen |
title | Paracentral acute middle maculopathy in Susac syndrome after dual exposure to SARS-CoV-2 antigen |
title_full | Paracentral acute middle maculopathy in Susac syndrome after dual exposure to SARS-CoV-2 antigen |
title_fullStr | Paracentral acute middle maculopathy in Susac syndrome after dual exposure to SARS-CoV-2 antigen |
title_full_unstemmed | Paracentral acute middle maculopathy in Susac syndrome after dual exposure to SARS-CoV-2 antigen |
title_short | Paracentral acute middle maculopathy in Susac syndrome after dual exposure to SARS-CoV-2 antigen |
title_sort | paracentral acute middle maculopathy in susac syndrome after dual exposure to sars-cov-2 antigen |
topic | Case Reports: Unusual association of diseases/symptoms |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092144/ https://www.ncbi.nlm.nih.gov/pubmed/35537770 http://dx.doi.org/10.1136/bcr-2021-247159 |
work_keys_str_mv | AT malerbifernandokorn paracentralacutemiddlemaculopathyinsusacsyndromeafterdualexposuretosarscov2antigen AT schoepsviniciusandreoli paracentralacutemiddlemaculopathyinsusacsyndromeafterdualexposuretosarscov2antigen AT tfmatoskimble paracentralacutemiddlemaculopathyinsusacsyndromeafterdualexposuretosarscov2antigen |